arrow-left-endarrow-right-end

News & Updates

The Latest on Internet Pharmacies, Supplements, Designer Drugs,
and Other High-Risk Merchants

Filter By:

The Proliferation of Ketamine Infusion Clinics Presents Opportunities and Uncertainty

In a cautious win for off-label prescribing, one of the world’s most commonly used drugs for more than 50 years has recently evolved into what can only be described as a phenomenon in the treatment of severe depression and suicidal ideation. Ketamine — a psychoactive analgesic (pain-blocking) sedative — is considered by many in the…

Continue Reading ›

Addiction Treatment Certification One Year In: Why It’s More Important Than Ever

LegitScript recently celebrated the one-year anniversary of the launch of our Drug and Alcohol Addiction Treatment Certification program, and our certification team reflected on both the  lessons and accomplishments of this monumental program. As a member of the customer success team, I see firsthand the value our customers get out of certification. But more importantly,…

Continue Reading ›

Bing Adopts LegitScript Addiction Treatment Certification Standards

I’m happy to announce that, starting in March, Bing will require LegitScript certification for providers of drug and alcohol addiction treatment who want to advertise in the United States. The certification program, which launched in July 2018, is now recognized by Bing, Google, and Facebook for addiction treatment providers looking to advertise. According Melissa Alsoszatai-Petheo,…

Continue Reading ›

LegitScript’s New Certification Program for Addiction Treatment Providers Will Help Those Most Vulnerable

I’m pleased to announce that today, LegitScript is launching a certification program for drug and alcohol addiction treatment providers. I’m also pleased to share that Google, also today, announced that starting in July, all drug and alcohol addiction treatment providers in the United States that wish to advertise on Google AdWords will be required to…

Continue Reading ›

As Opiate Addiction Explodes, So Do Supplement Companies Looking to Cash In

In a public health crisis, some people see suffering while others see profits. The Food and Drug Administration frequently warns consumers about fraudulent or unapproved products that sprout up during disease outbreaks such as Zika, H1N1, or Ebola. But what about a different kind of outbreak — the opioid epidemic? More than 64,000 Americans died…

Continue Reading ›